These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 21720771)

  • 1. Distribution of the activity of the angiotensin-converting enzyme in the rat aorta and changes in the activity with aging and by the action of L-NAME.
    Korystova AF; Emel'yanov MO; Kublik LN; Levitman MKh; Shaposhnikova VV; Kim YA; Korystov YN
    Age (Dordr); 2012 Aug; 34(4):821-30. PubMed ID: 21720771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of taxifolin on the activity of angiotensin-converting enzyme and reactive oxygen and nitrogen species in the aorta of aging rats and rats treated with the nitric oxide synthase inhibitor and dexamethasone.
    Arutyunyan TV; Korystova AF; Kublik LN; Levitman MKh; Shaposhnikova VV; Korystov YN
    Age (Dordr); 2013 Dec; 35(6):2089-97. PubMed ID: 23271616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
    De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
    Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low doses of ethanol decrease the activity of the angiotensin-converting enzyme in the aorta of aging rats and rats treated with a nitric oxide synthase inhibitor and dexamethasone.
    Emel'yanov MO; Korystova AF; Kublik LN; Levitman MKh; Shaposhnikova VV; Korystov YN
    Clin Sci (Lond); 2012 Jan; 122(2):75-81. PubMed ID: 21767262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenic role of oxidative stress in vascular angiotensin-converting enzyme activation in long-term blockade of nitric oxide synthesis in rats.
    Usui M; Egashira K; Kitamoto S; Koyanagi M; Katoh M; Kataoka C; Shimokawa H; Takeshita A
    Hypertension; 1999 Oct; 34(4 Pt 1):546-51. PubMed ID: 10523324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-converting enzyme inhibitor prevents plasminogen activator inhibitor-1 expression in a rat model with cardiovascular remodeling induced by chronic inhibition of nitric oxide synthesis.
    Katoh M; Egashira K; Mitsui T; Chishima S; Takeshita A; Narita H
    J Mol Cell Cardiol; 2000 Jan; 32(1):73-83. PubMed ID: 10652192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic morphological alterations, glycogen content and cytochrome P450 activities in rats treated chronically with N(omega)-nitro-L-arginine methyl ester (L-NAME).
    Tarsitano CA; Paffaro VA; Pauli JR; da Silva GH; Saad MJ; Salgado I; da Cruz-Höfling MA; Hyslop S
    Cell Tissue Res; 2007 Jul; 329(1):45-58. PubMed ID: 17436021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of ACE inhibitors on vascular endothelial dysfunction induced by exogenous advanced oxidation protein products in rats.
    Chen SX; Song T; Zhou SH; Liu YH; Wu SJ; Liu LY
    Eur J Pharmacol; 2008 Apr; 584(2-3):368-75. PubMed ID: 18334254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide production and endothelium-dependent vasorelaxation induced by wine polyphenols in rat aorta.
    Andriambeloson E; Kleschyov AL; Muller B; Beretz A; Stoclet JC; Andriantsitohaina R
    Br J Pharmacol; 1997 Mar; 120(6):1053-8. PubMed ID: 9134217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptidase activities in rats treated chronically with N(omega)-nitro-L-arginine methyl ester (L-NAME).
    Linardi A; Panunto PC; Ferro ES; Hyslop S
    Biochem Pharmacol; 2004 Jul; 68(2):205-14. PubMed ID: 15193992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term treatment with N(omega)-nitro-L-arginine methyl ester causes arteriosclerotic coronary lesions in endothelial nitric oxide synthase-deficient mice.
    Suda O; Tsutsui M; Morishita T; Tanimoto A; Horiuchi M; Tasaki H; Huang PL; Sasaguri Y; Yanagihara N; Nakashima Y
    Circulation; 2002 Sep; 106(13):1729-35. PubMed ID: 12270870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term low-dose angiotensin converting enzyme inhibitor treatment increases vascular cyclic guanosine 3',5'-monophosphate.
    Gohlke P; Lamberty V; Kuwer I; Bartenbach S; Schnell A; Linz W; Schölkens BA; Wiemer G; Unger T
    Hypertension; 1993 Nov; 22(5):682-7. PubMed ID: 8225528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Important role of tissue angiotensin-converting enzyme activity in the pathogenesis of coronary vascular and myocardial structural changes induced by long-term blockade of nitric oxide synthesis in rats.
    Takemoto M; Egashira K; Usui M; Numaguchi K; Tomita H; Tsutsui H; Shimokawa H; Sueishi K; Takeshita A
    J Clin Invest; 1997 Jan; 99(2):278-87. PubMed ID: 9005996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impairment of smooth muscle function of rat thoracic aorta in an endothelium-independent manner by long-term administration of N(G)-nitro-L-arginine methyl ester.
    López RM; Ortíz CS; Ruíz A; Vélez JM; Castillo C; Castillo EF
    Fundam Clin Pharmacol; 2004 Dec; 18(6):669-77. PubMed ID: 15548238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Augmentation of pulse wave velocity precedes vascular structural changes of the aorta in rats treated with N(omega)-nitro-L-arginine methyl ester.
    Kameyama H; Takeda K; Kusaba T; Narumiya H; Tanda S; Kuwahara N; Yamada K; Tamagaki K; Okigaki M; Hatta T; Sasaki S
    Hypertens Res; 2005 May; 28(5):439-45. PubMed ID: 16156508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enalapril and quinapril improve endothelial vasodilator function and aortic eNOS gene expression in L-NAME-treated rats.
    De Gennaro Colonna V; Rossoni G; Rigamonti A; Bonomo S; Manfredi B; Berti F; Muller E
    Eur J Pharmacol; 2002 Aug; 450(1):61-6. PubMed ID: 12176110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of NO in the endothelium-independent relaxing effects of N(omega)-hydroxy-L-arginine and other compounds bearing a C=NOH function in the rat aorta.
    Vetrovsky P; Boucher JL; Schott C; Beranova P; Chalupsky K; Callizot N; Muller B; Entlicher G; Mansuy D; Stoclet JC
    J Pharmacol Exp Ther; 2002 Nov; 303(2):823-30. PubMed ID: 12388669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium channel blockades exhibit anti-inflammatory and antioxidative effects by augmentation of endothelial nitric oxide synthase and the inhibition of angiotensin converting enzyme in the N(G)-nitro-L-arginine methyl ester-induced hypertensive rat aorta: vasoprotective effects beyond the blood pressure-lowering effects of amlodipine and manidipine.
    Toba H; Nakagawa Y; Miki S; Shimizu T; Yoshimura A; Inoue R; Asayama J; Kobara M; Nakata T
    Hypertens Res; 2005 Aug; 28(8):689-700. PubMed ID: 16392774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of L-nitroarginine to inhibit the activity of aortic inducible nitric oxide synthase.
    Darblade B; Batkai S; Caussé E; Gourdy P; Fouque MJ; Rami J; Arnal JF
    J Vasc Res; 2001; 38(3):266-75. PubMed ID: 11399899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the role of nitric oxide in the relaxant effect of the crude extract and fractions from Eugenia uniflora in the rat thoracic aorta.
    Wazlawik E; Da Silva MA; Peters RR; Correia JF; Farias MR; Calixto JB; Ribeiro-Do-Valle RM
    J Pharm Pharmacol; 1997 Apr; 49(4):433-7. PubMed ID: 9232544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.